Cargando…

Exploring mutation specific beta blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers

The congenital long QT syndrome (LQTS), one of the most common cardiac channelopathies, is characterized by delayed ventricular repolarization underlying prolongation of the QT interval of the surface electrocardiogram. LQTS is caused by mutations in genes coding for cardiac ion channels or ion chan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Comollo, Thomas W., Zou, Xinle, Zhang, Chuangeng, Kesters, Divya, Hof, Thomas, Sampson, Kevin J., Kass, Robert S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373745/ https://www.ncbi.nlm.nih.gov/pubmed/35949058 http://dx.doi.org/10.1080/19336950.2022.2106025

Ejemplares similares

Modeling Tissue- and Mutation- Specific Electrophysiological Effects in the Long QT Syndrome: Role of the Purkinje Fiber
por: Iyer, Vivek, et al.
Publicado: (2014)

Pharmacological rescue of specific long QT variants of KCNQ1/KCNE1 channels
por: Zou, Xinle, et al.
Publicado: (2022)

Two small-molecule activators share similar effector sites in the KCNQ1 channel pore but have distinct effects on voltage sensor movements
por: Chen, Lei, et al.
Publicado: (2022)

PERTURBATION OF SODIUM CHANNEL STRUCTURE BY AN INHERITED LONG QT SYNDROME MUTATION
por: Glaaser, Ian W., et al.
Publicado: (2012)

Comparison of QT peak and QT end interval responses to autonomic adaptation in asymptomatic LQT1 mutation carriers
por: Haapalahti, Petri, et al.
Publicado: (2011)

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation
por: Matsa, Elena, et al.
Publicado: (2011)

Concise Review: Criteria for Chamber‐Specific Categorization of Human Cardiac Myocytes Derived from Pluripotent Stem Cells
por: Kane, Christopher, et al.
Publicado: (2017)

The Role of KCNQ1 Mutations and Maternal Beta Blocker Use During Pregnancy in the Growth of Children With Long QT Syndrome
por: Huttunen, Heta, et al.
Publicado: (2018)

Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
por: Chehade, Rania, et al.
Publicado: (2016)

Generation of Functional Myocytes from Equine Induced Pluripotent Stem Cells
por: Amilon, Karin R., et al.
Publicado: (2018)

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
por: Page, Elizabeth C., et al.
Publicado: (2019)

Effects of Mexiletine on a Race-specific Mutation in Na(v)1.5 Associated With Long QT Syndrome
por: Wu, Xin, et al.
Publicado: (2022)

The Disease-Specific Phenotype in Cardiomyocytes Derived from Induced Pluripotent Stem Cells of Two Long QT Syndrome Type 3 Patients
por: Fatima, Azra, et al.
Publicado: (2013)

Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome
por: Bellin, Milena, et al.
Publicado: (2013)

Differentiation of patient-specific void urine-derived human induced pluripotent stem cells to fibroblasts and skeletal muscle myocytes
por: Kibschull, M., et al.
Publicado: (2023)

Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells
por: Stillitano, Francesca, et al.
Publicado: (2017)

Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics
por: Terrenoire, Cecile, et al.
Publicado: (2013)

Isoform-Specific Dominant-Negative Effects Associated with hERG1 G628S Mutation in Long QT Syndrome
por: Stump, Matthew R., et al.
Publicado: (2012)

Novel CALM3 mutations in pediatric long QT syndrome patients support a CALM3-specific calmodulinopathy
por: Chaix, Marie-A., et al.
Publicado: (2016)

Distinct electrophysiological and mechanical beating phenotypes of long QT syndrome type 1-specific cardiomyocytes carrying different mutations
por: Kiviaho, Anna L., et al.
Publicado: (2015)

TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
por: Del-Aguila, Jorge L., et al.
Publicado: (2019)

Adiponectin isoform patterns in ethnic-specific ADIPOQ mutation carriers: The IRAS Family Study
por: Tabb, Keri L., et al.
Publicado: (2017)

Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes
por: Matsa, Elena, et al.
Publicado: (2014)

Recurrent and Founder Mutations in the Netherlands: the Long-QT Syndrome
por: Hofman, N., et al.
Publicado: (2010)

Genotype- and Sex-Specific QT-RR Relationship in the Type-1 Long-QT Syndrome
por: Couderc, Jean-Philippe, et al.
Publicado: (2012)

Short QT and atrial fibrillation: A KCNQ1 mutation–specific disease. Late follow-up in three unrelated children
por: Sarquella-Brugada, Georgia, et al.
Publicado: (2015)

Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes
por: Paci, Michelangelo, et al.
Publicado: (2018)

Germline specification from pluripotent stem cells
por: Yao, Chunmeng, et al.
Publicado: (2022)

Reversed Apico-Basal Myocardial Relaxation Sequence During Exercise in Long QT Syndrome Mutations Carriers With History of Previous Cardiac Events
por: Charisopoulou, Dafni, et al.
Publicado: (2022)

Visualizing Mutation-Specific Differences in the Trafficking-Deficient Phenotype of Kv11.1 Proteins Linked to Long QT Syndrome Type 2
por: Hall, Allison R., et al.
Publicado: (2018)

The compound mutation, a model for acquire long QT syndrome
por: Morita, Hiroshi
Publicado: (2012)

Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3
por: Iyer, Vivek, et al.
Publicado: (2015)

Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes
por: Ma, Dongrui, et al.
Publicado: (2015)

Corrected QT interval in electrocardiogram recordings in patients treated with calcium channel blockers
por: Wołek, Małgorzata, et al.
Publicado: (2023)

Contrasting Mutation Rates from Specific-Locus and Long-Term Mutation-Accumulation Procedures
por: Drake, John W.
Publicado: (2012)

An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval
por: Lorberbaum, Tal, et al.
Publicado: (2016)

From gene-specific to function-specific risk stratification in long QT syndrome Type 2: implications for clinical management
por: Crotti, Lia
Publicado: (2023)

Myocyte Enhancer Factor-2A Gene Mutation and Coronary Artery Disease
por: Jiang, Ying, et al.
Publicado: (2015)

Specific functional pathologies of Cx43 mutations associated with oculodentodigital dysplasia
por: Kelly, John J., et al.
Publicado: (2016)

Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells
por: Sala, Luca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aobtfahqgvve6tajlkpk17jadk